| + |
glucose | up-regulates quantity by stabilization 
|
Hexokinase |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-270265 |
|
|
Homo sapiens |
ES-2 Cell |
| pmid |
sentence |
| 26323688 |
Consistently, treatment of cells with 2-deoxy-d-glucose (2DG), which completely inhibits glucose metabolism, leads to HK2 degradation and cell death in combination with C43 |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
SLC2A2 | up-regulates quantity
relocalization
|
glucose |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-267386 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 25421524 |
The glucose transporter isoform GLUT2 is expressed in liver, intestine, kidney and pancreatic islet beta cells, as well as in the central nervous system, in neurons, astrocytes and tanycytes. Physiological studies of genetically modified mice have revealed a role for GLUT2 in several regulatory mechanisms. In pancreatic beta cells, GLUT2 is required for glucose-stimulated insulin secretion. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
glucose | up-regulates quantity by stabilization
|
HK2 |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-261323 |
|
|
Homo sapiens |
ES-2 Cell |
| pmid |
sentence |
| 26323688 |
Consistently, treatment of cells with 2-deoxy-d-glucose (2DG), which completely inhibits glucose metabolism, leads to HK2 degradation and cell death in combination with C43 |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
glucose | down-regulates activity 
|
AMPK |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-256137 |
|
|
Mus musculus |
Myoblast |
| pmid |
sentence |
| 18477450 |
Glucose restriction (GR) impaired differentiation of skeletal myoblasts and was associated with activation of the AMP-activated protein kinase (AMPK). |
|
| Publications: |
1 |
Organism: |
Mus Musculus |
| Pathways: | Acute Myeloid Leukemia, IDH-TET in AML |
| + |
glucose | down-regulates activity
|
PRKAA1 |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-256136 |
|
|
Mus musculus |
Myoblast |
| pmid |
sentence |
| 18477450 |
Glucose restriction (GR) impaired differentiation of skeletal myoblasts and was associated with activation of the AMP-activated protein kinase (AMPK). |
|
| Publications: |
1 |
Organism: |
Mus Musculus |
| + |
SLC2A1 | up-regulates quantity
relocalization
|
glucose |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-267460 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 23506862 |
GLUT1 plays a critical role in cerebral glucose uptake as the major GLUT isoform expressed in brain endothelial cells. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
SLC2A3 | up-regulates quantity
relocalization
|
glucose |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-267461 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 23506862 |
GLUThe SLC2A3 gene encoding GLUT3 was first cloned from a human fetal skeletal muscle cell line (Kayano et al., 1988). It shares ~64% sequence identity with SLC2A1. GLUT3 has a higher apparent affinity (lower Km) and a higher maximum turnover number for glucose than the other Class 1 GLUT proteins, and its principal physiological substrate is clearly D-glucose T1 plays a critical role in cerebral glucose uptake as the major GLUT isoform expressed in brain endothelial cells. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
SLC2A4 | up-regulates quantity
relocalization
|
glucose |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-267288 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 17403369 |
Skeletal muscle both stores glucose as glycogen and oxidizes it to produce energy following the transport step. The principal glucose transporter protein that mediates this uptake is GLUT4, which plays a key role in regulating whole body glucose homeostasis |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
3.0
glucose
